Estados financieros detallados de Mesa Laboratories, Inc. (MLAB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Mesa Laboratories, Inc. registró ingresos de $249.1M en el último ejercicio fiscal, con un CAGR de 5 años del 13.2%. El beneficio neto alcanzó $6.7M, con un CAGR a 5 años del 15.4%.
Márgenes de los últimos 12 meses: margen bruto 66.0%, margen operativo 9.0%, margen neto 1.9%. El flujo de caja libre creció a un CAGR del 2.4% en 5 años.
Al precio actual de $125.29, MLAB cotiza a un P/E de 145.69 y un ROE del 2.59%. La capitalización bursátil es de $701M.
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Ingresos | $93.7M | $96.2M | $103.1M | $117.7M | $133.9M | $184.3M | $219.1M | $216.2M | $241.0M | $249.1M |
| Coste de Ventas | $40.4M | $41.6M | $42.2M | $52.3M | $46.9M | $75.2M | $85.4M | $82.9M | $90.1M | $90.9M |
| Beneficio Bruto | $53.2M | $54.6M | $60.9M | $65.4M | $87.0M | $109.1M | $133.7M | $133.2M | $150.9M | $158.3M |
| I+D | $4.2M | $3.5M | $3.5M | $6.4M | $10.4M | $15.8M | $20.5M | $19.3M | $19.5M | $20.3M |
| Generales y Administrativos | $32.8M | $35.1M | $39.6M | $51.1M | $64.3M | $88.6M | $109.9M | $111.5M | $115.0M | $119.5M |
| Gastos Operativos | $36.9M | $38.6M | $43.1M | $57.4M | $74.7M | $104.4M | $130.4M | $405.3M | $134.5M | $139.8M |
| Beneficio Operativo | $16.3M | $2.2M | $9.8M | $7.9M | $12.4M | $4.7M | $3.3M | -$272.1M | $16.3M | $18.5M |
| EBITDA | $25.1M | $9.8M | $18.1M | $22.4M | $28.0M | $32.5M | $37.5M | -$238.4M | $42.3M | $35.3M |
| Gastos por Intereses | 0 | $1.9M | 0 | $5.5M | $8.0M | $3.9M | $4.8M | $5.7M | $11.9M | $10.7M |
| Beneficio Antes de Impuestos | $14.3M | $301000 | $8.6M | $3.9M | $2.3M | $3.6M | -$389000 | -$275.6M | $6.0M | $12.0M |
| Impuestos | $3.1M | $3.3M | $1.1M | $2.1M | -$971000 | $1.7M | -$1.3M | -$21.4M | $7.9M | $5.3M |
| Beneficio Neto | $11.2M | -$3.0M | $7.5M | $1.8M | $3.3M | $1.9M | $930000 | -$254.2M | -$2.0M | $6.7M |
| BPA | $3.04 | $-0.79 | $1.95 | $0.32 | $0.66 | $0.36 | $0.17 | $-47.20 | $-0.36 | $1.22 |
| BPA Diluido | $2.91 | $-0.79 | $1.86 | $0.31 | $0.64 | $0.35 | $0.17 | $-47.20 | $-0.36 | $1.21 |
| Acciones en Circulación (Diluidas) | $3.8M | $3.8M | $4.0M | $4.4M | $5.1M | $5.3M | $5.4M | $5.4M | $5.4M | $5.6M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $60.7M | $65.1M | $63.7M | $60.1M |
| Beneficio Bruto | $37.3M | $41.8M | $46.6M | $39.0M |
| Beneficio Operativo | $4.7M | $8.0M | $2.7M | $7.0M |
| EBITDA | $10.7M | $13.3M | $4.2M | $12.4M |
| Beneficio Neto | $2.5M | $3.6M | -$4.1M | $2.8M |
| BPA | $0.45 | $0.66 | $-0.75 | $0.50 |
| BPA Diluido | $0.45 | $0.65 | $-0.75 | $0.49 |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Caja y Equivalentes | $5.8M | $5.5M | $10.2M | $81.4M | $263.9M | $49.3M | $32.9M | $28.2M | $27.3M | $26.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $14.3M | $14.3M | $12.5M | $21.1M | $23.8M | $41.2M | $42.6M | $39.1M | $42.0M | $44.1M |
| Inventario | $13.9M | $9.2M | $6.8M | $14.2M | $11.2M | $24.6M | $34.6M | $32.7M | $25.4M | $26.4M |
| Activos Corrientes | $35.8M | $32.0M | $33.6M | $122.8M | $303.7M | $124.3M | $119.0M | $109.4M | $102.7M | $106.3M |
| Inmovilizado Material | $26.0M | $23.6M | $22.2M | $22.1M | $22.0M | $28.6M | $28.1M | $41.4M | $32.3M | $48.1M |
| Fondo de Comercio | $72.2M | $65.5M | $66.4M | $141.5M | $160.8M | $291.2M | $286.4M | $180.1M | $181.8M | $186.9M |
| Activos Intangibles | $37.8M | $42.9M | $33.2M | $119.9M | $111.7M | $250.1M | $216.8M | $113.8M | $96.9M | $83.3M |
| Activos Totales | $171.7M | $164.1M | $156.8M | $420.2M | $601.5M | $707.4M | $661.8M | $446.8M | $433.3M | $427.7M |
| Cuentas por Pagar | $2.2M | $2.4M | $2.9M | $3.4M | $4.5M | $7.9M | $6.1M | $6.0M | $5.7M | $4.9M |
| Deuda a Corto | $1.1M | $1.6M | $2.1M | 0 | 0 | 0 | 0 | 0 | $101.0M | $5.6M |
| Pasivos Corrientes | $16.6M | $17.3M | $23.7M | $26.0M | $32.6M | $48.1M | $43.4M | $44.3M | $164.0M | $61.9M |
| Deuda a Largo | $53.7M | $44.6M | $20.6M | $140.3M | $145.7M | $218.4M | $183.3M | $221.7M | $76.9M | $145.9M |
| Pasivos Totales | $73.9M | $64.7M | $45.5M | $200.2M | $195.2M | $313.6M | $268.4M | $301.4M | $273.5M | $241.5M |
| Reservas | $73.7M | $68.3M | $73.3M | $71.9M | $72.5M | $76.7M | $74.2M | -$183.5M | -$188.9M | -$185.7M |
| Patrimonio Neto | $97.8M | $99.4M | $111.3M | $220.0M | $406.2M | $393.8M | $393.5M | $145.4M | $159.8M | $186.2M |
| Deuda Total | $54.8M | $46.3M | $22.7M | $141.4M | $146.7M | $221.1M | $186.1M | $231.3M | $181.5M | $168.8M |
| Deuda Neta | $49.0M | $40.8M | $12.6M | $60.0M | -$117.2M | $171.8M | $153.2M | $203.1M | $154.2M | $141.9M |
| Capital Circulante | $19.2M | $14.7M | $10.0M | $96.8M | $271.2M | $76.3M | $75.6M | $65.0M | -$61.3M | $44.4M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $20.4M | $29.0M | $26.9M | $30.7M |
| Activos Totales | $430.4M | $434.8M | $427.7M | $419.2M |
| Pasivos Totales | $251.9M | $248.2M | $241.5M | $230.5M |
| Patrimonio Neto | $178.5M | $186.7M | $186.2M | $188.8M |
| Deuda Total | $190.4M | $181.0M | $155.2M | $101.4M |
Flujo de Caja (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Beneficio Neto | $11.2M | -$3.0M | $7.5M | $1.3M | $3.3M | $1.9M | $930000 | -$254.2M | -$2.0M | $6.7M |
| Amortizaciones | $8.7M | $9.5M | $9.4M | $13.0M | $17.7M | $25.1M | $33.1M | $31.6M | $24.5M | $23.3M |
| Compensación en Acciones | $1.4M | $1.7M | $4.2M | $5.5M | $9.3M | $11.4M | $12.5M | $11.9M | $13.1M | $17.9M |
| Cambio en Capital Circulante | -$13.0M | $3.2M | $7.9M | -$3.1M | $5.3M | -$7.2M | -$17.1M | $6.0M | $6.9M | -$5.0M |
| Flujo de Caja Operativo | $7.8M | $24.8M | $30.6M | $26.6M | $37.1M | $39.2M | $28.0M | $44.1M | $46.8M | $42.8M |
| Inversiones (CapEx) | -$11.6M | -$2.8M | -$1.3M | -$1.5M | -$2.0M | -$4.4M | -$4.5M | -$2.6M | -$4.5M | -$3.2M |
| Adquisiciones | -$6.8M | -$15.5M | -$4.8M | -$184.1M | 0 | -$300.8M | -$5.0M | -$78.7M | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$5.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | -$2.4M | -$2.4M | -$2.5M | -$2.7M | -$3.2M | -$3.3M | -$3.4M | -$3.4M | -$3.5M | -$3.5M |
| Flujo de Caja Libre | -$3.9M | $22.0M | $29.3M | $25.1M | $35.1M | $34.8M | $23.4M | $41.6M | $42.3M | $39.6M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | $8.2M | $18.8M | $14.0M | $14.7M |
| Inversiones (CapEx) | -$1.1M | -$732000 | $2.8M | -$559000 |
| Flujo de Caja Libre | $7.1M | $18.0M | $16.8M | $14.2M |
| Dividendos Pagados | -$882000 | -$884000 | -$884000 | -$884000 |
| Compensación en Acciones | $3.8M | $3.4M | -$11.1M | $2.4M |
Crecimiento y Márgenes (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| Crecimiento Ingresos (anual) | | +2.7% | +7.2% | +14.1% | +13.8% | +37.6% | +18.8% | -1.3% | +11.5% | +3.4% |
| Crecimiento Beneficio Neto (anual) | | -126.5% | +352.7% | -76.2% | +84.1% | -42.9% | -50.3% | -27438.3% | +99.2% | +440.0% |
| Crecimiento BPA (anual) | | -126.0% | +346.8% | -83.6% | +106.2% | -45.5% | -52.8% | -27864.7% | +99.2% | +438.9% |
| Cambio en Acciones (anual) | | -1.9% | +7.0% | +8.4% | +17.2% | +4.1% | +0.5% | +0.5% | +0.8% | +2.5% |
| Crecimiento FCF (anual) | | +671.1% | +33.1% | -14.4% | +40.0% | -0.8% | -32.6% | +77.3% | +1.8% | -6.4% |
| Margen Bruto | 56.8% | 56.8% | 59.1% | 55.5% | 65.0% | 59.2% | 61.0% | 61.6% | 62.6% | 63.5% |
| Margen Operativo | 17.4% | 2.3% | 9.5% | 6.7% | 9.2% | 2.6% | 1.5% | -125.9% | 6.8% | 7.4% |
| Margen EBITDA | 26.7% | 10.2% | 17.5% | 19.0% | 20.9% | 17.6% | 17.1% | -110.3% | 17.6% | 14.2% |
| Margen Neto | 11.9% | -3.1% | 7.3% | 1.5% | 2.4% | 1.0% | 0.4% | -117.6% | -0.8% | 2.7% |
| Margen FCF | -4.1% | 22.9% | 28.4% | 21.3% | 26.2% | 18.9% | 10.7% | 19.2% | 17.6% | 15.9% |
| Tasa Impositiva Efectiva | 21.8% | 1084.1% | 13.2% | 54.0% | -42.2% | 47.6% | 339.1% | 7.8% | 133.1% | 44.1% |
Datos por Acción (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| FCF por Acción | $-1.00 | $5.84 | $7.26 | $5.73 | $6.85 | $6.52 | $4.37 | $7.72 | $7.79 | $7.11 |
| Dividendo por Acción | $0.61 | $0.64 | $0.61 | $0.62 | $0.62 | $0.63 | $0.64 | $0.64 | $0.64 | $0.63 |
| Acciones en Circulación (Básicas) | $3.7M | $3.7M | $3.8M | $4.2M | $5.0M | $5.2M | $5.3M | $5.4M | $5.4M | $5.5M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | 2.59% |
| Rentabilidad sobre capital invertido | 3.05% |
| Rentabilidad sobre activos | 1.14% |
| Margen bruto | 65.99% |
| Margen operativo | 9.00% |
| Margen neto | 1.92% |
Salud financiera
| Deuda / Patrimonio | 0.54 |
| Ratio corriente | 2.07 |
| Piotroski F-Score | 7 |
| Altman Z-Score | 1.45 |
Ratios Clave (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|
| P/E | 40.36 | -187.90 | 117.38 | 706.53 | 368.94 | 708.00 | 1027.82 | -2.37 | -329.61 | 72.48 |
| P/VC | 4.61 | 5.60 | 7.89 | 4.32 | 2.98 | 3.37 | 2.36 | 4.15 | 4.03 | 2.62 |
| P/V | 4.82 | 5.79 | 8.52 | 8.07 | 9.04 | 7.21 | 4.24 | 2.79 | 2.67 | 1.96 |
| Margen Bruto | 56.8% | 56.8% | 59.1% | 55.5% | 65.0% | 59.2% | 61.0% | 61.6% | 62.6% | 63.5% |
| Margen Operativo | 17.4% | 2.3% | 9.5% | 6.7% | 9.2% | 2.6% | 1.5% | -125.9% | 6.8% | 7.4% |
| Margen Neto | 11.9% | -3.1% | 7.3% | 1.5% | 2.4% | 1.0% | 0.4% | -117.6% | -0.8% | 2.7% |